SG10201912979UA - Composition for inhibiting carnosine dipeptidase - Google Patents

Composition for inhibiting carnosine dipeptidase

Info

Publication number
SG10201912979UA
SG10201912979UA SG10201912979UA SG10201912979UA SG10201912979UA SG 10201912979U A SG10201912979U A SG 10201912979UA SG 10201912979U A SG10201912979U A SG 10201912979UA SG 10201912979U A SG10201912979U A SG 10201912979UA SG 10201912979U A SG10201912979U A SG 10201912979UA
Authority
SG
Singapore
Prior art keywords
composition
carnosine dipeptidase
inhibiting carnosine
inhibiting
dipeptidase
Prior art date
Application number
SG10201912979UA
Inventor
Shinya Fukizawa
Hiroshi Watanabe
Keiichi Abe
Original Assignee
Suntory Holdings Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Suntory Holdings Ltd filed Critical Suntory Holdings Ltd
Publication of SG10201912979UA publication Critical patent/SG10201912979UA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/121—Ketones acyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
SG10201912979UA 2015-12-16 2016-12-16 Composition for inhibiting carnosine dipeptidase SG10201912979UA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2015245446 2015-12-16
JP2015245449 2015-12-16

Publications (1)

Publication Number Publication Date
SG10201912979UA true SG10201912979UA (en) 2020-02-27

Family

ID=59056714

Family Applications (2)

Application Number Title Priority Date Filing Date
SG11201804160SA SG11201804160SA (en) 2015-12-16 2016-12-16 Composition for inhibiting carnosine dipeptidase
SG10201912979UA SG10201912979UA (en) 2015-12-16 2016-12-16 Composition for inhibiting carnosine dipeptidase

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SG11201804160SA SG11201804160SA (en) 2015-12-16 2016-12-16 Composition for inhibiting carnosine dipeptidase

Country Status (4)

Country Link
JP (1) JPWO2017104777A1 (en)
SG (2) SG11201804160SA (en)
TW (1) TW201733619A (en)
WO (1) WO2017104777A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019043846A1 (en) * 2017-08-30 2019-03-07 大塚製薬株式会社 Kaempferol analog-containing composition
WO2020085459A1 (en) * 2018-10-26 2020-04-30 国立大学法人東京大学 Antioxidation agent, antiglycation agent or anti-inflammatory agent
JP7356808B2 (en) * 2019-03-04 2023-10-05 株式会社ノエビア Skin external preparations
JP2020183346A (en) * 2019-04-26 2020-11-12 ロート製薬株式会社 Oral composition
CN114209851B (en) * 2021-12-17 2023-08-29 同济大学 Curcumin-silicon oxide nano drug-loading system and preparation method and application thereof

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2811353B2 (en) * 1990-07-06 1998-10-15 ゼリア新薬工業株式会社 Inflammatory bowel disease preventive and therapeutic agent
JPH07223940A (en) * 1994-02-14 1995-08-22 Pola Chem Ind Inc Active oxygen eliminating agent and composition containing the same
JP4082823B2 (en) * 1999-05-06 2008-04-30 日本メナード化粧品株式会社 Phototoxicity inhibitor
JP4719372B2 (en) * 2000-06-21 2011-07-06 花王株式会社 PPAR-dependent gene transcription activator
JP2002293736A (en) * 2001-03-30 2002-10-09 Sunstar Inc Maillard reaction inhibitor and composition containing the same
JP2003212774A (en) * 2002-01-22 2003-07-30 Ichimaru Pharcos Co Ltd Maillard reaction inhibitor
JP2005533042A (en) * 2002-06-10 2005-11-04 オクラホマ　メディカル　リサーチ　ファウンデーション Methods for using linked bis (polyhydroxyphenyl) and its O-alkyl derivatives in the treatment of inflammatory conditions of the central nervous system
WO2004064866A1 (en) * 2003-01-20 2004-08-05 Innovative Vision Products, Inc. Combined use of carnosinase inhibitor with l-carnosines and composition
JP2005104850A (en) * 2003-09-26 2005-04-21 Kanazawa Univ Tlo Inc Therapeutic agent and prophylactic agent for alzheimer's disease
JP5089025B2 (en) * 2004-04-30 2012-12-05 東海物産株式会社 Antioxidant composition
JP2006160721A (en) * 2004-11-09 2006-06-22 Kao Corp Agent for recovery from fatigue of cerebrum
WO2007116987A1 (en) * 2006-03-31 2007-10-18 Nippon Meat Packers, Inc. Functional food and drug having learning function-improving effect and antidepressant effect
EP1982707A1 (en) * 2007-04-18 2008-10-22 DSMIP Assets B.V. Use of hydroxytyrosol as anti-aging agent
JPWO2009136587A1 (en) * 2008-05-08 2011-09-08 株式会社カネカ Anti-fatigue composition
JP2013107852A (en) * 2011-11-21 2013-06-06 Morishita Jintan Co Ltd Maillard reaction inhibitor
JP6224899B2 (en) * 2013-03-07 2017-11-01 森永製菓株式会社 Hypoglycemic agent

Also Published As

Publication number Publication date
WO2017104777A1 (en) 2017-06-22
JPWO2017104777A1 (en) 2018-10-04
SG11201804160SA (en) 2018-06-28
TW201733619A (en) 2017-10-01

Similar Documents

Publication Publication Date Title
HUS2400003I1 (en) Compounds useful as kinase inhibitors
HK1253915A1 (en) Composition for surface modification
PT3371190T (en) Heterocyclic compounds as pi3k-gamma inhibitors
HK1258445A1 (en) Functional composition for surface modification
HK1249901B (en) Compounds useful for inhibiting ror-gamma-t
SG10201912979UA (en) Composition for inhibiting carnosine dipeptidase
GB201501004D0 (en) Inhibitors
PT3589637T (en) Compounds useful for inhibiting ror-gamma-t
HK1252798A1 (en) Composition for nebulizers
SI3589638T1 (en) Compounds useful for inhibiting ror-gamma-t
GB201520949D0 (en) Inhibitors
GB201522245D0 (en) Compounds useful as kinase inhibitors
GB201520189D0 (en) Compound for use